T2 Biosystems, Inc. (TTOO) Covered Calls

T2 Biosystems Inc is an in vitro diagnostic company. It has developed proprietary platform that enables direct detection of pathogens, biomarkers and other abnormalities across various unpurified patient sample types.

There are no covered calls available for T2 Biosystems, Inc..

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed an innovative and proprietary technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies. The company uses T2 Magnetic Resonance platform to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2 Biosystems was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.